MENU
AKRO
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Akero Therapeutics (AKRO) Ownership - Who owns Akero Therapeutics?
Profile
Industry
N/A
Address
601 Gateway Boulevard
Phone
+1 650 487-6488
Employees
56
Web
https://www.akerotx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.99B
P/E Ratio
N/A
Total Cash
760.19M
Projected Growth
N/A
Total Debt
36.27M
Revenue
N/A
Risk (Beta)
-0.79
Dividend Yield
N/A
Total Cash/Share
10.95
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
AKRO
Capitalization
1.99B
P/E Ratio
N/A
Risk (Beta)
-0.79
Dividend Yield
N/A
Total Cash
760M
Total Cash/Share
10.95
Total Debt
36.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
798M
P/B Ratio
2.49
Cash Flow
N/A
Earnings
-3.44
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
24.89
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-200.16M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-26.71
Shares Held By Institutions
2.7B
Shares Outstanding - Current
69.4M
Total Liabilities
67M
Total Volume MTD
N/A
Value
N/A
Gain YTD
20.557
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biotechnology company, which specializes in transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
601 Gateway Boulevard
Phone
+1 650 487-6488
Employees
56
Web
https://www.akerotx.com